ID Training Grant for Post-doctoral Fellows in Virology and Microbial Immunology

The ID division has a training grant for fellows interested in bench science research. One or two fellows per year can choose to pursue training in ID Epidemiology at Penn's Center for clinical Epidemiology and Biostatistics. Candidates generally enroll in the Masters of Science in Clinical Epidemiology (MSCE) curriculum, which includes 2 years of course work in epidemiology, biostatistics, health measurement, and protocol development. MSCE training also includes a design and conduct of a mentored research thesis project focusing n patient-oriented clinical research. Fellows who enter this program should be committed to a career path that includes spending the majority of time performing patient-oriented research. Fellows seeking a position on the training grant are asked to indicate their interest on the Fellowship Application. Candidates are selected during the first year of the ID fellowship based on commitment to clinical research and qualifications. For more information on the Clinical Epidemiology and Biostatistics (CCEB) program at Penn, see the following CCEB web site and the MSCE degree program.

Mentors for patient-oriented research are listed below, and generally are Senior Scholars in the Center for Clinical Epidemiology and Biostatistics. Fellows are asked to indicate on their application if they want to be considered as candidates for training grant positions. The interview day for those interested in applying will be organized accordingly.

Mentors for Patient-Oriented Research Training (areas of expertise):

• Katrina Armstrong, M.D., MSCE; (Preventive care to high risk populations)
• David Asch, M.D., M.B.A. (Moral and cognitive determinants of medical decisions)
• Kurt Barnhardt, M.D., MSCE (Obstetrics, Oncology and Epidemiology; Microbicide Development)
• Jeffrey Bergelson, M.D. (Enterovirus interaction with receptors; cell biology of virus entry)
• Greg Bisson, MD, MSCE; (Epidemiology of HIV, Tuberculosis)
• Emily Blumberg, M.D.(Infections in Transplant Patients)
• Frederic D. Bushman, Ph.D (HIV, poxvirus, systems biology of microbe-host interactions)
• Gary Cohen, Ph.D (events that mediate HSV entry into cells and promote the pathogenesis of the virus in humans)
• Ronald Collman, M.D. ( HIV infection of human macrophages and HIV use of co-receptors for entry into CNS)
• Robert W. Doms, M.D./Ph.D (HIV-1 coreceptors used in entry)
• Francisco Gonzalez-Scarano (Pathophysiology of HIV dementia)
• Roselyn Eisenberg, Ph.D. (events that mediate HSV entry into cells and promote the pathogenesis of the virus in humans)
• Neil Fishman, M.D. (Antibiotic Cost Containment and Infection Control)
• Nigel W. Fraser, Ph.D (HSV-1 latency in a mouse model system)
• Ian Frank, M.D. (HIV antiretroviral therapy, lipodystrophy)
• Harvey Friedman, M.D. (HIV, HSV patient-oriented research)
• Robert Gross M.D., MSCE (Adherence to HIV therapy)
• James Hoxie, M.D. (Identifying viral and cellular determinants relevant to the ability of HIV and SIV to infection and induce cytopathic effects)
• Stuart Isaacs, M.D., (Poxviruses as models to study viral proteins involved in pathogenesis, dissemination, evasion of host immune responses)
• Jay Kostman, M.D. (HIV-HepC co-infection)
• Ebbing Lautenbach, M.D., MPH, MSCE (Antimicrobial Resistance; healthcare-acquired infections)
• Darren R. Linkin, MD, MSCE (Healthcare acquired infections; antimicrobial resistance)
• Vincent Lo Re, MD, MSCE (HIV, hepatitis)
• Rob Roy MacGregor, M.D. (Opportunistic Infections)
• Joshua Metlay, M.D., PhD (Antimicrobial Drug Prescribing and Drug Resistance)
• Luis J. Montaner, DVM, D Phil (mechanisms of disease in HIV-1 infection and novel approaches to augment immune)
• Yvonne Paterson, Ph.D (Enhancing immune responses to design more effective vaccines against viral diseases)
• Timothy Rebbeck, Ph.D ( Molecular Epidemiologic Research)
• Steven Reiner, M.D., (HIV immunopathogenesis: antigen presentation by dendritic cells as a vaccine strategy)
• Mindy Schuster, M.D. (Fungal Infections in Oncology Patients)<
• J. Sanford Schwartz, M.D. (Medial Interventions and Medical Decision Making)
• Phillip Scott, Ph.D (the biology of T helper cell subsets in the development and regulation of immune response to Leishmania major)
• Hao Shen, Associate Professor of Microbiology (Immunological memory and vaccines against infectious agents)
• Guido Silvestri, M.D. (HIV pathogenesis and vaccines)
• Gary Smith, DPhil (Infections and Parasitic diseases of man and animals)
• Brian Storm, MD, MPH (Pharmacoepidemiology)
• Pablo Tebas, M.D.(HIV antiretroviral therapy, metabolic disorders)
• Jeffery Weiser, M.D (study of pneumococcal pathogenesis)
• Susan Weiss, Ph.D. (study of mouse hepatitis virus as a model systems for the study of human demyelinated diseases such as multiple sclerosis)
• Drew Weissman, M.D./Ph.D (HIV immunopathogenesis: antigen presentation by dendritic cells as a vaccine stratety)